4.0 Review

Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis

Journal

FLY
Volume 16, Issue 1, Pages 275-298

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/19336934.2022.2087484

Keywords

Drosophila; neurodegenerative diseases; reverse translational research

Funding

  1. Japan Agency for Medical Research and Developmennt (AMED) [JP22ek019484s]
  2. Ministry of Education, Culture, Sports, Science and Technology of Japan [18K14835, 18J00367, 21K15619, 19K22592, 21H02837]
  3. Sasakawa Scientific Research Grant
  4. GSK Japan Research Grant 2022

Ask authors/readers for more resources

The use of Drosophila in neurodegenerative disease research has contributed to the identification of modifier genes for the pathology and revealed the molecular pathologies involved in human neurological diseases.
The use of Drosophila in neurodegenerative disease research has contributed to the identification of modifier genes for the pathology. The basis for neurodegenerative disease occurrence in Drosophila is the conservation of genes across species and the ability to perform rapid genetic analysis using a compact brain. Genetic findings previously discovered in Drosophila can reveal molecular pathologies involved in human neurological diseases in later years. Disease models using Drosophila began to be generated during the development of genetic engineering. In recent years, results of reverse translational research using Drosophila have been reported. In this review, we discuss research on neurodegenerative diseases; moreover, we introduce various methods for quantifying neurodegeneration in Drosophila.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available